In response to NIC treatment, expression of survivin was upregulated in both xenograft and MDA-MB-231 breast cancer cells (Fig. 3c), thus supporting the proposal that NIC provides survival benefit to the cancer cells which led to increased tumor uptake in mice model. Here, BIRC5 is linked to breast cancer.